Delivery Order SPE2DB22D3501-SPE2DB25FXG39
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Praxbind (idarucizumab) injection. The $2,881.90 firm-fixed price delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,527.60 firm-fixed-price contract is for the delivery of PRAXBIND 5G DOSE (2x 2.5G/50ML) 50ML, with a period of performance through April 25, 2024. This order is a part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,527.60 firm fixed-price delivery order contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024 and was awarded on October 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,881.90 firm fixed-price contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product. The delivery order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML medical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,763.80 and an ultimate completion date of October 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Pradaxa 150 mg capsules (60-count units) with a ceiling value of $1,960.47. This firm fixed price delivery order, which has an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- This is a delivery order contract with a ceiling value of $2,881.90 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product, with a performance period ending on May 10, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,831.35 firm fixed-price delivery order is for the supply of 4,559,470,705 units of Pradaxa 150 mg capsules. The contract has an ultimate completion date of December 30, 2022 and was awarded on December 29, 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,073.11, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,136.94 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of March 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG39Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,433.40 to AmerisourceBergen Drug Corp for the supply of Praxbind (idarucizumab) 5G dose in 2x 2.5G/50ML vials, with a firm fixed-price contract type and an ultimate completion date of October 1, 2025. This award, issued on September 10, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the parent vehicle enabling this delivery order. Praxbind is a reversal agent used in emergency medical settings to counteract the anticoagulant effects of dabigatran, a blood thinner commonly prescribed to military beneficiaries and veterans. This delivery order reflects the DLA's ongoing need to maintain adequate supplies of critical emergency pharmaceutical products across the defense healthcare system. AmerisourceBergen's selection as the awardee underscores its established capability to fulfill federal medical supply requirements, supported by its extensive portfolio of pharmaceutical deliveries and competitive standing within the DLA's Medical Supply Chain. The company's comprehensive IDC allows it to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/10/25 |